[ Price : $8.95]
Attorney Steven Casey says the law remains unsettled on the question of who is liable for adverse reactions patients experience wh...[ Price : $8.95]
CDRH associate director for international affairs Kimberly Trautman says that medical device stakeholders worldwide have an opport...[ Price : $8.95]
FDA asks its Anti-infective Drugs Advisory Committee to comment on the efficacy and safety of Human Genome Sciences raxibacumab fo...[ Price : $8.95]
Federal Register Notice: FDA amends a notice of a 11/29 meeting of the Cellular, Tissue and Gene Therapies Advisory Committee to m...[ Price : $8.95]
A bill being floated on Capitol Hill to establish a nationwide drug tracking system allows tracking at the lot level and not at th...[ Price : $8.95]
FDA grants approval for GI Dynamics to initiate a clinical trial of EndoBarrier for treating patients who have uncontrolled Type 2...[ Price : $8.95]
Neuraltus says it is planning a Phase 3 trial of its NP001 in patients with Lou Gehrigs disease.[ Price : $8.95]
FDA approves the first of four PMA modules submitted by Cohera Medical for its TissuGlu Surgical Adhesive product.